Market Overview:
The global probucol market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cardiovascular diseases, increasing awareness about the benefits of probucol, and growing demand for probucol from hospital pharmacies, retail pharmacies, and online pharmacies. However, the high cost of probucol is expected to restrain the growth of this market during the forecast period.
 Industry Outlook.svg)
Product Definition:
Probucol is a cholesterol-lowering drug that also has anti-inflammatory and antioxidant effects. Probucol (CAS 23288-49-5) is used to treat high blood cholesterol levels and to prevent heart disease.
0.25g/Tablet:
0.25g tablet is a unit dosage form of probucol used as an expectorant in the treatment of chronic bronchitis and emphysema, acute respiratory failure and cystic fibrosis. It works by reducing excessive mucus production in the lungs which obstructs airflow, thus enabling breathing through airways that are obstructed due to mucus.
0.125g/Tablet:
0.125g tablet is used in the manufacturing of probucol, a natural carminative substance extracted from various plants including Eucalyptus Globulus, Mentha Arvensis and Thymus Serrae. It helps in stimulating the flow of digestive juices and acts as an anti-inflammatory agent by inhibiting prostaglandins production which results in reduced inflammation response along with pain relief.
Application Insights:
The market is segmented by application into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacy segment held the largest share of the global Probucol (CAS 23288-49-5) market in 2017 owing to increasing demand for convenient healthcare services. Moreover, this segment is expected to grow at a rapid pace over the forecast period due to growing internet usage rates across developing countries such as India and China.
In addition, factors such as rising disposable income levels among consumers coupled with an increase in spending on pharmaceutical products are anticipated to boost product demand in near future. Probucol tablets are used for various health conditions including cardiovascular diseases and diabetes mellitus type 2 which require medication throughout the day along with meals.
Regional Analysis:
Europe was the largest market for probucol, accounting for a share of more than 35.0% in 2017 owing to high demand from countries, such as Russia and Ukraine.
Moreover, factors such as favorable government policies aimed at improving public health system and availability & accessibility related issues are anticipated boost growth over next eight years in this region which will lead it becoming largest market by 2030 timeframe.
Growth Factors:
- Probucol is a cholesterol-lowering agent that has been shown to be more effective than other agents in lowering low-density lipoprotein (LDL) cholesterol levels.
- Probucol has anti-inflammatory and antioxidant properties, which may help protect the heart from damage.
- Probucol can improve the function of endothelial cells, which line the inside of blood vessels and play an important role in maintaining cardiovascular health.
- Probucol may help prevent or delay the development of atherosclerosis, a condition that can lead to heart attack or stroke.
- Some studies have shown that probucol may also be beneficial for people with diabetes by helping to control blood sugar levels and preventing diabetic complications
Scope Of The Report
Report Attributes
Report Details
Report Title
Probucol (CAS 23288-49-5) Market Research Report
By Type
0.25g/Tablet, 0.125g/Tablet
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Qilu Pharma, JFPKG, Otsuka Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Probucol (CAS 23288-49-5) Market Report Segments:
The global Probucol (CAS 23288-49-5) market is segmented on the basis of:
Types
0.25g/Tablet, 0.125g/Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qilu Pharma
- JFPKG
- Otsuka Pharma
 Market Overview.svg)
Highlights of The Probucol (CAS 23288-49-5) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.25g/Tablet
- 0.125g/Tablet
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Probucol (CAS 23288-49-5) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Probucol is a cholesterol-lowering drug that is used to treat high blood pressure, heart disease, and other conditions.
Some of the key players operating in the probucol (cas 23288-49-5) market are Qilu Pharma, JFPKG, Otsuka Pharma.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Probucol (CAS 23288-49-5) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Probucol (CAS 23288-49-5) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Probucol (CAS 23288-49-5) Market - Supply Chain
4.5. Global Probucol (CAS 23288-49-5) Market Forecast
4.5.1. Probucol (CAS 23288-49-5) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Probucol (CAS 23288-49-5) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Probucol (CAS 23288-49-5) Market Absolute $ Opportunity
5. Global Probucol (CAS 23288-49-5) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Type
5.3.1. 0.25g/Tablet
5.3.2. 0.125g/Tablet
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Probucol (CAS 23288-49-5) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Probucol (CAS 23288-49-5) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Probucol (CAS 23288-49-5) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Probucol (CAS 23288-49-5) Demand Share Forecast, 2019-2026
9. North America Probucol (CAS 23288-49-5) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Type
9.7.1. 0.25g/Tablet
9.7.2. 0.125g/Tablet
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Probucol (CAS 23288-49-5) Demand Share Forecast, 2019-2026
10. Latin America Probucol (CAS 23288-49-5) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Type
10.7.1. 0.25g/Tablet
10.7.2. 0.125g/Tablet
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Probucol (CAS 23288-49-5) Demand Share Forecast, 2019-2026
11. Europe Probucol (CAS 23288-49-5) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Type
11.7.1. 0.25g/Tablet
11.7.2. 0.125g/Tablet
11.8. Basis Point Share (BPS Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Probucol (CAS 23288-49-5) Demand Share, 2019-2026
12. Asia Pacific Probucol (CAS 23288-49-5) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Type
12.7.1. 0.25g/Tablet
12.7.2. 0.125g/Tablet
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Probucol (CAS 23288-49-5) Demand Share, 2019-2026
13. Middle East & Africa Probucol (CAS 23288-49-5) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Probucol (CAS 23288-49-5) Market Size and Volume Forecast by Type
13.7.1. 0.25g/Tablet
13.7.2. 0.125g/Tablet
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Probucol (CAS 23288-49-5) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Probucol (CAS 23288-49-5) Market: Market Share Analysis
14.2. Probucol (CAS 23288-49-5) Distributors and Customers
14.3. Probucol (CAS 23288-49-5) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Qilu Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. JFPKG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Otsuka Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
